AstraZeneca(AZN)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£38,232m

Change Today

Price Up11.00p

Share Price

2,635.00p

Detailed AstraZeneca Share Price Data

Share Price 2,635.00p Price Up Close 2,624.00p
Change Today +11.00p Volume 3,050,970
Percent Change +0.42% Day High / Low 2,650.00p / 2,592.00p
Update Time 13:16:22 Year High / Low 2,766.00p / 1,748.00p
Bid 2,634.00p Last Trade Price 2,635.00p
Offer 2,636.00p Last Trade Amount 1,000
Open 2,626.00p Last Trade Time 13:16:22

Detailed AstraZeneca Share Price Changes

Period Price Change Percent Change
1 week 2,689.00p -65.00p -2.42%
1 month 2,549.00p +75.00p +2.94%
3 months 2,180.00p +444.00p +20.37%
6 months 1,855.00p +769.00p +41.46%
1 year 2,466.00p +158.00p +6.41%

Additional AstraZeneca Share Price Data

Ex-Marker Code Ex-Dividend NMS 4,000
Ex-Marker Start 06-Aug-08 VWAP 2,623.99p
Ex-Marker End 15-Sep-08 Beta 0.69

Related Market Prices

Index / Sector Value Change Percent Change
FTSE 100 5,312.30 -49.80 -0.93%
FTSE 350 2,773.50 -25.60 -0.91%
FTSE All-Share 2,716.27 -25.04 -0.91%
FTSEurofirst 300 1,137.33 -13.97 -1.21%
Pharmaceuticals & Biotechnology 8,405.10 +73.00 +0.88%
techMARK 1,428.74 -8.15 -0.57%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 2,635.00p Price Up
Change Today +11.00p
52 Week High 2,766.00
52 Week Low 1,748.00
Volume 3,050,970
Shares Issued 1,450.93m
Market Cap £38,232m
Beta 0.69
RiskGrade 139

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.4% below the market average65.4% below the market average65.4% below the market average65.4% below the market average65.4% below the market average
16.05% above the sector average16.05% above the sector average16.05% above the sector average16.05% above the sector average16.05% above the sector average
Price Trend
66.85% above the market average66.85% above the market average66.85% above the market average66.85% above the market average66.85% above the market average
73.03% above the sector average73.03% above the sector average73.03% above the sector average73.03% above the sector average73.03% above the sector average
Income
11.67% above the market average11.67% above the market average11.67% above the market average11.67% above the market average11.67% above the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Growth
47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average47.35% below the market average
19.44% below the sector average19.44% below the sector average19.44% below the sector average19.44% below the sector average19.44% below the sector average

What The Brokers Say

Strong Buy 13
Buy 3
Neutral 16
Sell 6
Strong Sell 3
Total 41
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Aug-08 06-Feb-08
Paid 15-Sep-08 17-Mar-08
Amount 55.00¢ 135.00¢

Trades for 05-Sep-2008

Time Volume / Share Price
13:16 1,000 @ 2,635.00p
13:15 21 @ 2,636.00p
13:15 87 @ 2,636.00p
13:15 349 @ 2,635.00p
13:15 513 @ 2,634.00p

AstraZeneca Key Personnel

CEO David R Brennan
CFO Simon Lowth

Digital Look have been voted
"Best Research and Information Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).